Product Images Esbriet

This appears to be a chart or graph depicting the percentage of a certain value (possibly related to lung function) over time, with two groups represented by ESBRIET and Placebo. The chart depicts a decline in the value over time for both groups. There are specific data points labeled on the chart representing the percentage change in the value at specific time points.*

This is a clinical trial result of Pirfenidone drug compared to Placebo for patients with a certain medical condition. The table shows the percentage of patients alive, Hazard ratio with confidence interval, patients at risk, and the time frame of the study. There is no information on the medical condition or the purpose of the study.*

Esbriet (pirfenidone) is a medication that comes in capsule form and is marketed by Genentech. The product is available in a bottle containing 270 capsules and the label warns to keep it out of reach of children. The National Drug Code (NDC) is 50242-121-01.*

This is a description of the medication with the NDC code 50242-122-06, marketed under the brand name Esbriet®. The medication contains pirfenidone and is available in tablet form. The label advises to keep the medication away from children and notes that it is only available with a prescription (R' only). The bottle contains 270 tablets and is manufactured by Genentech.*

This is a prescription medicine known as Esbriet (pirfenidone). Each bottle contains 90 tablets with the NDC code 50242-123-01 and a strength of 801 mg. The medication should be kept out of reach of children and is only to be used with a valid prescription (R' only). The manufacturer of this medicine is Genentech§.*